PTK2B and neoplasm: As a control, we used their counterpart EPN-PKM3 cells, which express a Proline-rich tyrosine kinase (PYK2) dead kinase mutant, and display some tumour-like features, like increased cell motility and migration, and cytoskeleton reorganization [39–42].